Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Analytical Method Development: SOP for Handling Method Development Failures – V 2.0

Posted on By

Analytical Method Development: SOP for Handling Method Development Failures – V 2.0

Standard Operating Procedure for Managing Method Development Failures in Analytical Method Development


Department Analytical Method Development
SOP No. SOP/AMD/348/2025
Supersedes SOP/AMD/348/2022
Page No. Page 1 of 14
Issue Date 01/06/2025
Effective Date 03/06/2025
Review Date 01/06/2026

1. Purpose

The purpose of this SOP is to define a standardized procedure for identifying, documenting, analyzing, and addressing failures that occur during analytical method development (AMD) activities. The objective is to ensure continuous improvement, compliance

with regulatory expectations, and scientific justification of failures and their resolutions.

2. Scope

This SOP is applicable to all AMD activities conducted in the laboratory where method development fails to meet predefined criteria such as specificity, precision, accuracy, linearity, robustness, or system suitability. It covers failures related to instrumentation, method parameters, reagents, and sample matrices.

3. Responsibilities

  • Method Developer: Identifies failure, halts activity, and initiates failure report.
  • AMD Supervisor: Conducts preliminary assessment and assigns investigation responsibilities.
  • Quality Assurance (QA): Reviews investigation findings and ensures CAPA implementation.
  • Instrument Engineer (if applicable): Supports technical diagnostics for instrument-related failures.
See also  Analytical Method Development: Development of Environmental Monitoring Plates - V 2.0

4. Accountability

The Head of Analytical Method Development is accountable for ensuring the integrity of the method development process and the scientific handling of failures in compliance with cGMP and ICH guidelines.

5. Procedure

5.1 Identification of Failure

  1. Recognize method development failure when observed results deviate significantly from expected trends or acceptance criteria.
  2. Failures may include abnormal chromatograms, poor peak resolution, unstable results, inconsistent recovery, or lack of linearity.
  3. Stop the method development activity immediately upon identification of failure.

5.2 Documentation and Intimation

  1. Record details of the failure in Annexure-1: Method Development Failure Report Form.
  2. Include method ID, analyst name, date, instrument used, reagent details, and brief observations.
  3. Notify AMD supervisor and QA immediately through internal communication channel.

5.3 Root Cause Investigation

  1. Initiate root cause analysis (RCA) using structured tools such as Fishbone diagram or 5 Whys technique.
  2. Investigate parameters such as reagent integrity, instrument performance, column condition, method variables (pH, mobile phase composition), and analyst technique.
  3. Document all findings in Annexure-2: RCA Worksheet and classify cause as assignable or unassignable.
See also  Analytical Method Development: SOP for Extractable Volume Determination - V 2.0

5.4 Categorization of Failure

  • Instrumental Failure: Malfunction of detector, pump, injector, or temperature controls.
  • Reagent/Column Issues: Expired, contaminated, or incorrectly prepared reagents or degraded column.
  • Method Parameter-Related: Inappropriate gradient, pH, flow rate, or detection wavelength.
  • Human Error: Incorrect preparation, sampling, calculation, or sequence setup.

5.5 Corrective and Preventive Action (CAPA)

  1. Based on RCA, propose CAPA with defined timelines and responsible personnel.
  2. Implement corrective measures (e.g., recalibration, retraining, column replacement, method optimization).
  3. Preventive actions may include checklist revision, SOP update, or additional system suitability tests.
  4. Record all CAPAs in Annexure-3: CAPA Implementation Log.

5.6 Reinitiation of Method Development

  1. After CAPA implementation, reinitiate method development using controlled parameters.
  2. Compare results with prior failed attempt and confirm performance improvement.
  3. Attach method revalidation outcome to the failure report and archive complete package.

6. Abbreviations

  • CAPA: Corrective and Preventive Action
  • RCA: Root Cause Analysis
  • cGMP: Current Good Manufacturing Practice
  • AMD: Analytical Method Development

7. Documents

  1. Annexure-1: Method Development Failure Report Form
  2. Annexure-2: RCA Worksheet
  3. Annexure-3: CAPA Implementation Log
See also  Analytical Method Development: SOP for Validation Report Preparation and Review - V 2.0

8. References

  • ICH Q9 – Quality Risk Management
  • ICH Q2(R1) – Validation of Analytical Procedures
  • 21 CFR Part 211 – GMP for Finished Pharmaceuticals

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name Akshay Verma Nidhi Rawat Dr. Arvind Bansal
Designation AMD Executive QA Officer Head – AMD
Department Analytical Method Development Quality Assurance Analytical Method Development

11. Annexures

Annexure-1: Method Development Failure Report Form

Captures method details, failure description, affected parameter(s), environmental conditions, and initial analyst comments.

Annexure-2: Root Cause Analysis (RCA) Worksheet

Structured documentation using fishbone diagram, listing probable causes under categories like Material, Instrument, Method, Analyst, and Environment.

Annexure-3: CAPA Implementation Log

CAPA ID Description Responsible Person Timeline Status
CAPA-AMD-348-01 Retraining on pH adjustment techniques Training Officer 10 Days Completed

Revision History:

Revision Date Revision No. Details Reason Approved By
01/06/2025 2.0 Expanded sections on CAPA and RCA tools Annual SOP Review Dr. Arvind Bansal
15/05/2022 1.0 Initial Release New SOP QA Head
Analytical Method Development V 2.0 Tags:Analytical Method Development SOP, SOP for analytical calculations, SOP for analytical documentation, SOP for analytical instrument calibration, SOP for analytical instrument qualification, SOP for analytical method change control, SOP for analytical method deviation handling, SOP for analytical method documentation practices, SOP for analytical method lifecycle management, SOP for analytical method optimization, SOP for analytical method risk assessment, SOP for analytical method training and competency, SOP for analytical method transfer protocol, SOP for analytical method validation, SOP for forced degradation studies, SOP for HPLC method development, SOP for limit of detection (LOD) determination, SOP for limit of quantitation (LOQ) determination, SOP for method accuracy testing, SOP for method linearity assessment, SOP for method precision evaluation, SOP for method reproducibility, SOP for method robustness testing, SOP for method transfer, SOP for method verification, SOP for qualification of working standards, SOP for reference standard handling, SOP for specificity testing in analytical methods, SOP for stability indicating methods, SOP for system suitability testing

Post navigation

Previous Post: Elixir Department: SOP for Deviation Management – V 2.0
Next Post: Elixir Department: SOP for Change Control Procedure – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2026 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version